Publications by authors named "William Olney"

Traumatic Brain Injury (TBI) remains a significant global health concern with significant impact on morbidity and mortality. This narrative review explores adjunctive pharmacologic agents to be employed by emergency medicine clinicians during Advanced Trauma Life Support (ATLS) in patients presenting with a TBI. Pharmacologic agents are commonly employed for the management of rapid sequence intubation and post-intubation analgosedation, hemodynamics, intracranial pressure, coagulopathy, seizure prophylaxis, and infection.

View Article and Find Full Text PDF

Background: Daptomycin is a high-use intravenous antimicrobial agent affording the convenience of once-daily dosing. Prior studies suggest an opportunity to use a more operationally convenient fixed rather than weight-based dosing but this approach has not been studied prospectively.

Methods: This study quantified the probability of toxicity and efficacy end points by prospectively testing a fixed dose regimen of daptomycin (750 mg) in obese and non-obese adults.

View Article and Find Full Text PDF

Appropriate antimicrobial therapy for the management of intra-abdominal infection (IAI) continues to evolve based on available literature. The Study to Optimize Peritoneal Infection Therapy (STOP-IT) trial provided evidence to support four days of antibiotic agents in IAI post-source control but excluded patients with a planned re-laparotomy. This study aimed to determine the short- and long-term recurrent infection risk in this population.

View Article and Find Full Text PDF

Pain, agitation, and delirium (PAD) are primary drivers of outcome in the ICU, and expertise in managing these entities successfully is crucial to the intensivist's toolbox. In addition, there are unique aspects of surgical patients that impact assessment and management of PAD. In this review, we address the continuous spectrum of assessment, and management of critically ill surgical patients, with a focus on limiting PAD, particularly incorporating mobility as an anchor to ICU liberation.

View Article and Find Full Text PDF
Article Synopsis
  • Buprenorphine is a key medication for treating opioid use disorder, and this study looks at how continuing this medication during surgery affects the need for opioid pain relief.
  • The study involved analyzing data from patients at a trauma center who were either continued on buprenorphine or had it withheld during their hospital stay, specifically focusing on their use of full mu-opioid agonists and their pain experiences.
  • Results showed that patients who continued buprenorphine used significantly fewer full mu-opioids, yet there was no difference in their pain levels or the length of their hospital stays compared to those who had buprenorphine withheld.
View Article and Find Full Text PDF

Background: Critically ill patients are at increased risk for fluid overload, but objective prediction tools to guide clinical decision-making are lacking. The MRC-ICU scoring tool is an objective tool for measuring medication regimen complexity.

Objective: To evaluate the relationship between MRC-ICU score and fluid overload in critically ill patients.

View Article and Find Full Text PDF
Article Synopsis
  • The review aims to assess the effectiveness of high-dose daptomycin (≥ 8 mg/kg/d) for treating serious gram-positive infections.
  • It highlights that high-dose daptomycin is particularly beneficial for conditions like endocarditis and bacteremia caused by methicillin-resistant bacteria, as well as potentially effective for osteomyelitis and CNS infections, though more comparative studies are needed.
  • The findings suggest clinicians should reconsider dosing standards for daptomycin, as higher doses may improve outcomes without significant safety issues in certain patient populations.
View Article and Find Full Text PDF

Background: The MRC-ICU, a novel regimen complexity scoring tool, provides an objective measure of medication regimen complexity in critically ill patients. The MRC-ICU may have the ability to evaluate the impact of critical care pharmacists on patient outcomes but requires further validation. The objective of this study was to confirm the external validity of the MRC-ICU scoring tool at multiple institutions and intensive care unit (ICU) settings.

View Article and Find Full Text PDF